Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Amasten Fastighets AB in connection with a directed share issue
Mandate

Vinge has advised Amasten Fastighets AB in connection with a directed share issue

September 15, 2020 Capital Markets and Public M&A

Vinge has advised Amasten Fastighets AB (“Amasten”), a real estate company, in connection with a directed share issue whereby Amasten receives SEK 500 million in issue proceeds.

The subscription price was determined to SEK 7.30 per share through an accelerated book building process. The share issue was directed to selected Swedish and international investors. The main purpose of the share issue is to finance continued growth through acquisitions of investment properties and development projects.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl, Malte St Cyr Ohm and Amanda M Johansson.

 

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025